Guys, It looks like the Professor has research grants through February 2022. I know very little about the Professors research, but believe he may have produced 2 molecules for further development in conjunction with the first grant from the US Army listed below. One molecule was an analog of trobalt which was purchased by SciFluor who then modified it further by including fluorine to make it more receptor specific and therefore more potent with fewer side effects. However, this molecule may have failed in preclinical animal studies. There was also another molecule which may have been more extensively modified, but I know nothing about it, who owns it or if its ever been tested in laboratory or animal studies. Attheedgeofscience may know more about it as he was part of a Tinnitus Talk team that explored this science including trobalt and KVreceptors. -TC
http://www.otolaryngology.pitt.edu/people/thanos-tzounopoulos-phd
Research Grants
U.S. Army-DOD, Tzounopoulos, Development of Therapeutic Drugs that Prevent the Triggering of Tinnitus, W81XWH-14-1-0117, July 2014 - July 2017
NIH, Tzounopoulos, Cell-Specific Synaptic Plasticity in the Auditory Brainstem, 5R01 DC007905, March 20076 - February 2022
Allergan, Tzounopoulos, Cortical Mechanisms Underlying Tinnitus, 5910001-20012000358, August 2016 - August 2019
NSF, Tzounopoulos, NSF-IOS-BSF: Influence of neuronal zinc homeostasis on cortical responses to sound, IOS-1655480, September 2017- July 2021